Hurdle (Decision/Risk Analysis) Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.92M

  • Investors
  • 9

Hurdle (Decision/Risk Analysis) General Information

Description

Developer of a diagnostic platform designed to facilitate better care, operational optimization, and personalized health interventions. The company's platform utilizes artificial intelligence to analyze diagnostic data and offer personalized and accurate diagnostics, enabling healthcare providers to improve accuracy, efficiency, scalability, and patient care.

Contact Information

Website
www.hurdle.bio
Formerly Known As
Chronomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bizspace Wimbledon
  • 8 Lombard Road
  • London SW19 3TZ
  • England, United Kingdom
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Bizspace Wimbledon
  • 8 Lombard Road
  • London SW19 3TZ
  • England, United Kingdom

Hurdle (Decision/Risk Analysis) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hurdle (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 26-Mar-2025 $7.92M Completed Generating Revenue
4. Later Stage VC 13-Sep-2023 Completed Generating Revenue
3. Seed Round 09-Jan-2019 Completed Generating Revenue
2. Angel (individual) $100K Completed Startup
1. Accelerator/Incubator 22-Dec-2017 $100K $100K Completed Startup
To view Hurdle (Decision/Risk Analysis)’s complete valuation and funding history, request access »

Hurdle (Decision/Risk Analysis) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Preferred Ordinary
Series A Preferred Ordinary
Seed 2 8,113 $0.012847 $170.67 $170.67 1x $170.67 3.97%
To view Hurdle (Decision/Risk Analysis)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hurdle (Decision/Risk Analysis) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic platform designed to facilitate better care, operational optimization, and personalized health
Decision/Risk Analysis
London, United Kingdom
33 As of 2024

San Francisco, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hurdle (Decision/Risk Analysis) Competitors (22)

One of Hurdle (Decision/Risk Analysis)’s 22 competitors is ixLayer, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ixLayer Venture Capital-Backed San Francisco, CA
DarioHealth Formerly VC-backed New York, NY
Cognoa Venture Capital-Backed Palo Alto, CA
Blue Mesa Health Private Equity-Backed New York, NY
MEMOTEXT Accelerator/Incubator Backed Bethesda, MD
You’re viewing 5 of 22 competitors. Get the full list »

Hurdle (Decision/Risk Analysis) Patents

Hurdle (Decision/Risk Analysis) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201810897-D0 Phenotype prediction Inactive 03-Jul-2018
WO-2020008192-A2 Phenotype prediction Inactive 03-Jul-2018
WO-2020008192-A3 Phenotype prediction Inactive 03-Jul-2018 G16B20/00

Hurdle (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hurdle (Decision/Risk Analysis) Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Expedite Capital Venture Capital Minority
Samos Investments Venture Capital Minority
Cola Blanca Investments Corporation Minority
Outsized Ventures Venture Capital Minority
Start Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Hurdle (Decision/Risk Analysis) FAQs

  • When was Hurdle (Decision/Risk Analysis) founded?

    Hurdle (Decision/Risk Analysis) was founded in 2017.

  • Where is Hurdle (Decision/Risk Analysis) headquartered?

    Hurdle (Decision/Risk Analysis) is headquartered in London, United Kingdom.

  • What is the size of Hurdle (Decision/Risk Analysis)?

    Hurdle (Decision/Risk Analysis) has 33 total employees.

  • What industry is Hurdle (Decision/Risk Analysis) in?

    Hurdle (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is Hurdle (Decision/Risk Analysis) a private or public company?

    Hurdle (Decision/Risk Analysis) is a Private company.

  • What is the current valuation of Hurdle (Decision/Risk Analysis)?

    The current valuation of Hurdle (Decision/Risk Analysis) is .

  • What is Hurdle (Decision/Risk Analysis)’s current revenue?

    The current revenue for Hurdle (Decision/Risk Analysis) is .

  • How much funding has Hurdle (Decision/Risk Analysis) raised over time?

    Hurdle (Decision/Risk Analysis) has raised $17.2M.

  • Who are Hurdle (Decision/Risk Analysis)’s investors?

    Expedite Capital, Samos Investments, Cola Blanca Investments, Outsized Ventures, and Start Capital are 5 of 9 investors who have invested in Hurdle (Decision/Risk Analysis).

  • Who are Hurdle (Decision/Risk Analysis)’s competitors?

    ixLayer, DarioHealth, Cognoa, Blue Mesa Health, and MEMOTEXT are some of the 22 competitors of Hurdle (Decision/Risk Analysis).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process